What side effects are reported with Kerendia (finerenone) 10 mg?
Kerendia (finerenone) is commonly associated with two main safety issues: elevated potassium (hyperkalemia) and changes in blood pressure. In the Kerendia prescribing information, hyperkalemia is emphasized as a key risk and requires potassium monitoring during treatment [1].
Other reported side effects can occur, but the exact frequency depends on the patient’s baseline kidney function, other medicines (especially RAAS blockers), and the dose.
Why does Kerendia cause hyperkalemia, and what should patients watch for?
Kerendia is a mineralocorticoid receptor antagonist. By blocking mineralocorticoid signaling in the kidney, it can reduce potassium excretion, which can raise blood potassium levels [1].
Because mild hyperkalemia may not cause symptoms, the main “what to watch for” is lab monitoring. Patients should follow their clinician’s instructions for periodic blood tests and report concerning symptoms such as weakness or unusual heart-rhythm sensations if they occur (these can be associated with high potassium) [1].
How much does Kerendia affect blood pressure?
By its mechanism, Kerendia can lower blood pressure. People starting or adjusting therapy may notice dizziness or lightheadedness, especially if they’re also on other antihypertensives [1].
If blood pressure drops too much or symptoms are bothersome, clinicians may adjust the dose or modify other blood pressure medications [1].
Who is at higher risk for side effects with Kerendia 10 mg?
Risk increases when a patient is more likely to develop hyperkalemia, such as those with reduced kidney function or those taking medicines that also raise potassium. This includes certain combinations with RAAS blockers and other therapies that affect potassium balance [1].
Clinicians typically adjust dose and monitoring intensity based on baseline potassium and kidney function [1].
What other medicines raise the risk of side effects?
Concomitant use of drugs that increase potassium can make hyperkalemia more likely. Clinicians often review the medication list carefully and may recommend changes to reduce risk. The prescribing information highlights the need for potassium monitoring when using interacting medicines [1].
If you tell me the other medications you take (names and doses), I can help identify which ones are commonly relevant to potassium risk, based on the prescribing information.
When should side effects lead to urgent care or a call to the prescriber?
Because hyperkalemia and blood pressure changes can be serious, patients should contact their clinician promptly if they have symptoms suggestive of high potassium or significant dizziness/lightheadedness. The prescribing information provides guidance on monitoring and managing potassium levels, including dose adjustments and interruption when needed [1].
If you have chest pain, fainting, severe weakness, or signs of a possible heart rhythm problem, seek emergency care.
Sources
- Drug information for Kerendia (finerenone) — DrugPatentWatch.com